Finally, Pollard wants to close the loop by incorporating code - writing approaches, such as genome editing using CRISPR - based approaches and synthetic biology, which are needed to test and
validate hypotheses and could also provide
novel therapies.
Graber will also lead the development of the Comparative Models of Regeneration Database (RegenDB), a
novel bioinformatics resource supported by the National Institutes of Health (NIH) whose function is to integrate gene function across multiple animal, tissue and cell models in order to
validate and inform the hypotheses needed for the discovery and development of regenerative medicine drug
therapies.